慢性髓性白血病干血斑二代测序:全球肿瘤学启示
Spot On CML项目优化干血斑DNA/RNA提取方法,在9国177例CML患者中检出ABL1突变61例(34%),最常见为T315I(占ABL1突变者45.9%);69例中检出89个其他基因Tier I-II变异,ASXL1变异与ABL1突变强相关(P=3.51E-04)。
要点
- 干血斑可提取DNA/RNA检测ABL1激酶域突变及其他髓系基因变异。
- 177例CML患者中34%检出ABL1突变,T315I占ABL1突变者45.9%。
- ASXL1变异与ABL1突变强相关(P=3.51E-04),69例中52个ASXL1变异。
核心结论
- 优化干血斑DNA/RNA提取方法可检测CML患者ABL1激酶域突变及其他髓系基因变异。
- 该方法有望将先进遗传分析推广至中低收入国家的CML患者。
研究设计与样本
- 基于Spot On CML项目的方法学研究,优化干血斑DNA和RNA提取。
- 纳入来自9个国家的177例CML患者,部分分析基于69例患者。
主要发现
- 177例中61例(34%)检出ABL1突变,部分病例存在多个突变。
- ABL1突变者中最常见为T315I,占45.9%。
- 69例中检出89个其他基因Tier I-II变异,包括49例患者的52个ASXL1变异。
- ASXL1变异与ABL1突变检出强相关(P=3.51E-04)。
临床怎么用
- 干血斑采样结合二代测序可用于CML诊断、预后和监测相关基因分析。
- 该方法适用于中低收入国家CML患者的遗传检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The goal of the "Spot On CML" program is to provide diagnostic and monitoring tests to chronic myeloid leukemia (CML) patients in low- and middle-income countries (LMICs). Previously, we demonstrated reproducible BCR::ABL1 transcript quantification using dried blood spots (DBS). We have now optimized methods of DNA and RNA extraction from DBS, allowing the detection of myeloid gene variants, including ABL1 tyrosine kinase domain mutations. Among 177 CML patients from nine countries, ABL1 mutations were identified in 61 (34%) patients, with multiple mutations present in some cases. The most common ABL1 mutation was T315I (45.9% of patients with ABL1 mutations). Among 69 patients, 89 Tier I-II variants (pathogenic or likely pathogenic) were identified in other genes, including 52 ASXL1 variants in 49 patients. The detection of ASXL1 variants correlated strongly with the presence of ABL1 mutations (P = 3.51E-04). These methodologies are directly applicable to all assays used for the diagnosis, prognosis, and monitoring of CML and have important implications in bringing state-of-the-art genetic analysis to CML patients in LMICs.
引用
- Oehler VG, Sala-Torra O, Gilderman N, et al. Next-generation sequencing from chronic myeloid leukemia dried blood spots: insights and implications for global oncology. Leukemia. 2026. PMID: 41577999. doi:10.1038/s41375-025-02852-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。